Abstract
Introduction
The major substrate underlying amphetamine (AMPH)-induced locomotor activity is associated with dopamine forebrain circuits. Brain regions associated with AMPH-induced locomotor activity express high levels of retinoid receptors. However, the role of these transcription factors in dopamine-mediated effects remains poorly understood. Two nuclear receptor families, the retinoic acid receptors (RAR) and the retinoid X receptors (RXR), transduce retinoic acid signal. RARs are specifically involved in retinoid signaling, whereas RXRs also participate in other signaling pathways as partners for other nuclear receptors such as Nur77, an orphan member of the nuclear receptor family expresses in dopamine system.
Materials and methods
To explore the role of retinoid receptors and Nur77 in AMPH-induced locomotor activity, we administered selective retinoid receptor drugs in combination with AMPH in adult wild-type and Nur77-deficient mice. At a low dose, AMPH similarly increased ambulatory activity in wild-type and Nur77-deficient mice, while it did not alter non-ambulatory activity.
Results and discussion
At a high dose, AMPH did not alter ambulatory activity anymore, while non-ambulatory activity strongly increased in wild-type mice. Nur77-deficient mice still displayed a higher ambulatory activity with no change in non-ambulatory activity. HX531, a synthetic RXR antagonist, blocks AMPH-induced ambulatory activity, whereas RAR drugs tested remained without effect. Interestingly, the effect of HX531 was abolished in Nur77-deficient mice, suggesting that this orphan nuclear receptor is essential for the action of the RXR drug.
Conclusion
This study shows that RXR and Nur77 participate in AMPH-induced locomotor activity and prompts for further investigations on the role of Nur77 and RXR in addiction and reward-related behaviors.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- AM80:
-
4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl]benzoic acid
- AMPH:
-
amphetamine
- DMSO:
-
dimethylsulfoxide
- HX531:
-
4-(5H-2,3-(2,5-dimethyl-2,5-hexano)-5-methyl-8-nitrodibenzo-[b,e][1,4]diazepin-11-yl)-benzoic acid
- LE135:
-
4-[5H-2,3-(2,5-dimethyl-2,5-hexano)-5-methyldibenzo-[b,e][1,4]diazepin-11-yl]-benzoic acid
- NGFI-B:
-
nerve-growth factor inducible gene B
- RAR:
-
retinoic acid receptor
- RXR:
-
retinoid X receptor
References
Amalric M, Koob GF (1993) Functionally selective neurochemical afferents and efferents of the mesocorticolimbic and nigrostriatal dopamine system. Prog Brain Res 99:209–226
Beaudry G, Langlois M-C, Weppe I, Rouillard C, Lévesque D (2000) Contrasting patterns and cellular specificity of transcriptional regulation of the nuclear receptor Nerve Growth Factor-Inducible B by haloperidol and clozapine in the rat forebrain. J Neurochem 75:1694–1702
Bhardwaj SK, Beaudry G, Quirion R, Lévesque D, Srivastava LK (2003) Neonatal ventral hippocampus lesion leads to reductions in Nerve Growth Factor Inducible-B mRNA in the prefrontal cortex and increased amphetamine response in the nucleus accumbens and dorsal striatum. Neuroscience 122:669–676
Chambon P (1996) A decade of molecular biology of retinoic acid receptors. FASEB J 10:940–954
Dickson PR, Lang CG, Hinton SC, Kelley AE (1994) Oral stereotypy induced by amphetamine microinjection into striatum: an anatomical mapping study. Neuroscience 61:81–91
Ebisawa M, Umemiya H, Ohta K, Fukasawa H, Kawachi E, Christoffel G, Gronemeyer H, Tsuji M, Hashimoto Y, Shudo K, Kagechika H (1999) Retinoid X receptor-antagonistic diazepinylbenzoic acids. Chem Pharm Bull (Tokyo) 47:1778–1786
Ethier I, Beaudry G, St-Hilaire M, Milbrandt J, Rouillard C, Lévesque D (2004a) The transcription factor NGFI-B (Nur77) and retinoids play a critical role in acute neuroleptic-induced extrapyramidal effect and striatal neuropeptide gene expression. Neuropsychopharmacology 29:335–346
Ethier I, Kagechika H, Shudo K, Rouillard C, Lévesque D (2004b) Docosahexaenoic acid reduces haloperidol-induced dyskinesias in mice: involvement of Nur77 and retinoid receptors. Biol Psychiatry 56:522–526
Fetsko LA, Xu R, Wang YY (2003) Alterations in D1/D2 synergism may account for enhanced stereotypy and reduced climbing in mice lacking dopamine D2L receptor. Brain Res 967:191–200
Gilbert F, Morissette M, St-Hilaire M, Paquet B, Rouillard C, Di Paolo T, Lévesque D (2006) Nur77 gene knockout alters dopamine neuron biochemical activity and dopamine turnover. Biol Psychiatry 60:538–547
Gonzalez-Nicolini V, McGinty JF (2002) Gene expression profile from the striatum of amphetamine-treated rats: a cDNA array and in situ hybridization histochemical study. Brain Res Gene Expr Patterns 1:193–198
Hyman SE, Malenka RC, Nestler EJ (2006) Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 29:565–598
Kagechika H, Shudo K (2005) Synthetic retinoids: recent developments concerning structure and clinical utility. J Med Chem 48:5875–5883
Kagechika H, Kawachi E, Hashimoto Y, Shudo K (1984) New type inducers of differentiation of human HL-60 promyelocytic leukemia cells. Terephthalic anilides. Chem Pharm Bull (Tokyo) 32:4209–4212
Krezel W, Ghyselinck N, Samad TA, Dupé V, Kastner P, Borrelli E, Chambon P (1998) Impaired locomotion and dopamine signaling in retinoid receptor mutant mice. Science 279:863–867
Krezel W, Kastner P, Chambon P (1999) Differential expression of retinoid receptors in the adult mouse central nervous system. Neuroscience 89:1291–1300
Langlois M-C, Beaudry G, Zekki H, Rouillard C, Lévesque D (2001) Impact of antipsychotic drug administration on the expression of nuclear receptors in the neocortex and striatum of the rat brain. Neuroscience 106:117–128
Lee SL, Wesselschmidt RL, Linette GP, Kanagawa O, Russell JH, Milbrandt J (1995) Unimpaired thymic and peripheral T cell death in mice lacking the nuclear receptor NGFI-B (Nur77). Science 269:532–535
Lévesque D, Rouillard C (2007) Nur77 and retinoid X receptors: crucial factors in dopamine-related neuroadaptation. Trends Neurosci 30:22–30
Li Y, Hashimoto Y, Agadir A, Kagechika H, Zhang X (1999) Identification of a novel class of retinoic acid receptor b-selective retinoid antagonists and their inhibitory effects on AP-1 activity and retinoic acid-induced apoptosis in human breast cancer cells. J Biol Chem 274:15360–15366
Maheux J, Ethier I, Rouillard C, Lévesque D (2005) Induction patterns of transcription factors of the Nur family (Nurr1, Nur77 and Nor-1) by typical and atypical antipsychotics in the mouse brain: Implication for their mechanism of action. J Pharmacol Exp Ther 313:460–473
Mangelsdorf DJ, Evans RM (1995) The RXR heterodimers and orphan receptors. Cell 83:841–850
Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schütz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM (1995) The nuclear receptor superfamily: the second decade. Cell 83:835–839
Mata de Urquiza A, Liu S, Sjöberg M, Zetterström RH, Griffiths W, Sjövall J, Perlmann T (2000) Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. Science 290:2140–2144
Miyamoto S, Snouwaert JN, Koller BH, Moy SS, Lieberman JA, Duncan GE (2004) Amphetamine-induced Fos is reduced in limbic cortical regions but not in the caudate or accumbens in a genetic model of NMDA receptor hypofunction. Neuropsychopharmacology 29:2180–2188
Morita K, Kawana K, Sodeyama M, Shimomura L, Kagechika H, Makishima M (2005) Selective allosteric ligand activation of the retinoid X receptor heterodimers of NGFI-B and Nurr1. Biochem Pharmacol 71:98–107
Nestler EJ (2004) Molecular mechanisms of drug addiction. Neuropharmacology 47(Suppl 1):24–32
Niculescu M, Ehrlich ME, Unterwald EM (2005) Age-specific behavioral responses to psychostimulants in mice. Pharmacol Biochem Behav 82:280–288
Perlmann T, Jansson L (1995) A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and NURR1. Genes Dev 9:769–782
Rojas P, Joodmardi E, Hong Y, Perlmann T, Ogren SO (2007) Adult mice with reduced Nurr1 expression: an animal model for schizophrenia. Mol Psychiatry 12:756–766
Saga Y, Kobayashi M, Ohta H, Murai N, Nakai N, Oshima M, Taketo MM (1999) Impaired extrapyramidal function caused by the targeted disruption of retinoid X receptor RXRγ1 isoform. Genes Cells 4:219–228
Shudo K, Kagechika H, Yamazaki N, Igarashi M, Tateda C (2004) A synthetic retinoid Am80 (tamibarotene) rescues the memory deficit caused by scopolamine in a passive avoidance paradigm. Biol Pharm Bull 27:1887–1889
St-Hilaire M, Tremblay P-O, Lévesque D, Barden N, Rouillard C (2003) Effects of cocaine on c-fos and NGFI-B mRNA expression in transgenic mice underexpressing glucocorticoid receptors. Neuropsychopharmacology 28:478–489
St-Hilaire M, Bourhis E, Lévesque D, Rouillard C (2006) Impaired behavioural and molecular adaptations to dopamine denervation and repeated L-DOPA treatment in Nur77 knockout mice. Eur J Neurosci 24:795–805
Valdenaire O, Maus-Moatti M, Vincent J-D, Mallet J, Vernier P (1998) Retinoic acid regulates the developmental expression of dopamine D2 receptor in rat striatal primary cultures. J Neurochem 71:929–936
Vezina P, Blanc G, Glowinski J, Tassin JP (1991) Opposed behavioural outputs of increased dopamine transmission in prefrontocortical and subcortical areas: a role for the cortical D-1 dopamine receptor. Eur J Neurosci 3:1001–1007
Wallen-Mackenzie A, de Urquiza AM, Petersson S, Rodriguez FJ, Friling S, Wagner J, Ordentlich P, Lengqvist J, Heyman RA, Arenas E, Perlmann T (2003) Nurr1-RXR heterodimers mediate RXR ligand-induced signaling in neuronal cells. Genes Dev 17:3036–3047
Werme M, Olson L, Brené S (2000) NGFI-B and Nor1 mRNAs are upregulated in brain reward pathways by drugs of abuse: different effects in Fischer and Lewis rats. Mol Brain Res 76:18–24
Yamauchi T, Waki H, Kamon J, Murakami K, Motojima K, Komeda K, Miki H, Kubota N, Terauchi Y, Tsuchida A, Tsuboyama-Kasaoka N, Yamauchi N, Ide T, Hori W, Kato S, Fukayama M, Akanuma Y, Ezaki O, Itai A, Nagai R, Kimura S, Tobe K, Kagechika H, Shudo K, Kadowaki T (2001) Inhibition of RXR and PPARγ ameliorates diet-induced obesity and type 2 diabetes. J Clin Invest 108:1001–1013
Zetterström RH, Williams R, Perlmann T, Olson L (1996) Cellular expression of the immediate-early transcription factors Nurr1 and NGFI-B suggests a gene regulatory role in several brain regions including the nigrostriatal dopamine system. Mol Brain Res 41:111–120
Zetterström RH, Lindqvist E, de Urquiza AM, Tomac A, Eriksson U, Perlmann T, Olson L (1999) Role of retinoids in the CNS: differential expression of retinoid binding proteins and receptors and evidence for presence of retinoic acid. Eur J Neurosci 11:407–416
Acknowledgments
We acknowledge the support of grants from the Canadian Institutes for Health Research (CIHR), the National Alliance for Research on Schizophrenia and Depression (NARSAD), and the Stanley Medical Research Institute (SMRI). DL holds a senior scholarship from the “Fonds de la Recherche en Santé du Québec” (FRSQ). EB and JM hold fellowships from the FRSQ and CIHR, respectively.
Disclosure/conflict of interest
The authors declare that they have no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bourhis, E., Maheux, J., Paquet, B. et al. The transcription factors Nur77 and retinoid X receptors participate in amphetamine-induced locomotor activities. Psychopharmacology 202, 635–648 (2009). https://doi.org/10.1007/s00213-008-1343-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-008-1343-0